Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.634, 2011-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Routine screening for prevention of neonatal kernicterus too costly?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. :
Access to resources
Recommend
Alemtuzumab: a costly alternative in CLL?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :
Tolcapone guidelines too restrictive?
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :
Pharmacogenomics commentary `too optimistic' ?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 383, 2002-01 ,pp. :
Extraimmunisation in paediatric patients - costly shots?
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :